Cellectar Biosciences Inc - Company Profile

All the data and insights you need on Cellectar Biosciences Inc in one report.

$295

Buy Report View Sample

Save hours of research time and resources with
our up-to-date Cellectar Biosciences Inc Strategy Report
Understand Cellectar Biosciences Inc position in the market,
performance and strategic initiatives.
Gain competitive edge and increase your
chances of success

Cellectar Biosciences Inc: Patents

View up-to-date information on Cellectar Biosciences Inc patents, including inventor and filing insights.

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
EP4041718A1	Application	PHOSPHOLIPID-FLAVAGLIN-KONJUGATE UND VERFAHREN ZU IHRER VERWENDUNG ZUR GEZIELTEN KREBSTHERAPIE	A61K31/665; A61P35/00; C07F9/65517	August 17, 2022
EP4041320A1	Application	FRAKTIONIERTE DOSIERUNG EINES PHOSPHOLIPID-ETHER-ANALOGS ZUR BEHANDLUNG VON KREBS	A61K51/0408; A61P35/00	August 17, 2022
EP4028018A1	Application	PHOSPHOLIPIDETHERKONJUGATE ALS GEGEN KREBS GERICHTETE TRÄGERSTOFFE	A61K38/05; A61K47/544; A61P35/00; C07F9/572; C07F9/60; C07F9/6512; C07F9/65517; C07F9/6558; C07F9/65586	July 20, 2022
KR1020220080149A	Application	암 치료를 위한 인지질 에테르 유사체의 분할 투여	A61K51/0408; A61P35/00	June 14, 2022
IL291980D0	Application	Fractionated dosing of a phospholipid ether analog for the treatment of cancer	A61K51/0408	June 01, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer